Navigation Links
Michigan Growth Capital Symposium Unveils Robust Line Up of Presenting Companies for 30th Anniversary Event
Date:5/2/2011

ANN ARBOR, Mich., May 2, 2011 /PRNewswire/ -- Anticipating record attendance among the investment community at the upcoming Michigan Growth Capital Symposium, taking place May 10-11 at the Marriott Resort in Ypsilanti, Mich., event organizers today unveiled the complete list of companies that will vie for funding at this year's event. The 41 presenting companies symbolize the "Best of the Midwest" businesses and were selected from a competitive pool of 85 applications.  During the past 10 years, more than 300 companies have presented at the Symposium. Seventy-one percent have raised capital totaling $1.7 billion in investment dollars and of those, 20 percent have gone on to realize successful exits.

This year's roster represents the Midwest industries that have emerged as having the greatest growth potential, including information technology, clean technology, medical devices and life science. Among them are seven University spinouts, including InPore Technologies and Life Magnetics, as well as companies traveling from as far as Kentucky and Massachusetts to participate. This year will mark an encore appearance for several companies, most notably Esperion Therapeutics. The Plymouth, Mich.-based biotech company presented in 1998, was bought out by Pfizer in 2004 for $1.3 billion and after divesting in 2008, is back to present at the Symposium in 2011.  

Nextronex Energy Systems, a Toledo, OH-based solar component manufacturing company, will be presenting at the Symposium for the first time, in the highly anticipated clean tech track. Commenting on the value of the event, CEO Bruce Larsen said: "Many of the companies that have presented at The Michigan Growth Capital Symposium have gone on to great success, which makes me confident that it is going to be a great forum for Nextronex. It has the clout to attract the influential Midwest and coastal VCs that we're eager to pitch, but it is still intimate enough that we'll be able to make one-on-one connections and cultivate relationships with them."

Hosted by the Ross School of Business' Zell Lurie Institute at the University of Michigan with support from the Michigan Venture Capital Association,  The Michigan Growth Capital Symposium, has become the gold standard for start-up investment in the Midwest. It serves as a conduit for introducing regional and national investors to promising startups and established, high growth organizations seeking funding. This year a new format has been expanded to include companies seeking angel and seed funding, as well as companies seeking follow-on rounds of funding up to $20 million.

"There is no question that the quality of presenting startups has improved, which is a testament to the fact that we are part of something major happening in the Midwest," said David Brophy, founder of the Symposium and professor of finance at University of Michigan Ross School of Business. "The light bulb has gone on. Large research universities are embracing technology transfer, talent is staying local and investors are doing deals here. I'm confident the next Michigan success story, akin to HealthMedia or Accuri, could be among this year's crop of presenting companies."

The complete list of presenting companies is now available at www.michigangcs.com.  Registration will remain open until May 9 at the same site.  To follow and contribute to conversations ahead of and during the event, track and use #MGCS on Twitter.

About the Michigan Growth Capital Symposium (MGCS)

MGCS is the original university-based venture fair, which was first held in 1979. This nationally attended two-day event provides an opportunity for financiers to connect with up-and-coming Midwest businesses and learn about emerging technologies. The Symposium offers the opportunity to build relationships with an unparalleled business network of distinguished private equity industry leaders and entrepreneurial business professionals. Entering its 30th year, MGCS continues to draw top investors from coast to coast. MGCS is presented by the Center for Venture Capital & Private Equity Finance at the Ross School of Business at the University of Michigan with support from the Michigan Venture Capital Association.


'/>"/>
SOURCE Michigan Growth Capital Symposium
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Michigan Home Medical Equipment Providers Back New Congressional Bill to Repeal Flawed Medicare Bidding Program
2. Detroit Medical Center Becomes First in Southeast Michigan to Study an Implantable Device, Designed to Reduce Patient Time to the ER and Improve Survival Rates From Heart Attack in High-Risk Patients
3. Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat
4. FDA: Michigan Heart-Lung Bypass Machine Manufacturer Enters Into Consent Decree
5. Zell Lurie Institute Awards $106,300 to University of Michigan Students Through the Michigan Business Challenge and Dare to Dream Startup Grant Program
6. Michigan Pre-Seed Capital Fund Reports Investments Totaling $2.5 Million in 2010
7. SurgiCount Medical Announces the Successful Implementation of the Safety-Sponge® System at the University of Michigan Health System
8. Exciting Healthcare News for Women of Mid Michigan
9. Southeastern Michigan Gets First Ever FDA Approved Device That Destroys Fat Cells ... Without Surgery
10. Business Accelerator Network for Southeast Michigan Announces Accelerate Michigan Innovation Competition
11. Michigan Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People With Disabilities Under Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017 Under the impetus ... packaging market size increased year by year at ... to 2021, the market size will maintain the ... to outnumber RMB140 billion in 2021, thanks to ... development of biological agents and supporting policies. ...
(Date:3/22/2017)... March 22, 2017 New Jersey,s ... of patient harm and saved $641 million in healthcare ... in a national quality improvement program. ... for Patients-New Jersey, part of a national initiative from ... selected the New Jersey Hospital Association and its affiliate, ...
(Date:3/22/2017)... Mar 22, 2017 Research and Markets ... Point Inhibitors Market & Clinical Pipeline Insight 2022" drug ... ... & Clinical Pipeline Insight 2022 report gives comprehensive insight on ... of immune check point inhibitors as main streamline drugs in ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... ... An intensive search of the medical literature has revealed no research yet on ... He says investigating this possibility, is important because Miami-Dade in 2016 led the U.S. ... , His findings appear on Analizir.com. . Dr. Norins, who trained ...
(Date:3/22/2017)... , ... March 22, 2017 , ... Last year, 43 ... a US Department of Agriculture report. While excess dairy can be caused by ... role. Lactose sensitivity is the inability to properly digest lactose, a sugar found in ...
(Date:3/22/2017)... ... 22, 2017 , ... The Vanderbeck Agency, a Long Island firm providing insurance, ... embarking on a combined charity effort with the Great Neck Breast Cancer Coalition to ... the Great Neck Breast Cancer Coalition has worked to support breast cancer patients in ...
(Date:3/22/2017)... ... 2017 , ... The Zabbia Insurance Agency, a Long Island ... owners in the greater Nassau County area, is embarking on a cancer awareness ... minutes, someone in America is diagnosed with blood cancer. Every 9 minutes, someone ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Senior Citizens League (TSCL) is ... default on the federal debt — including the debt held by the Social Security ... said TSCL in a letter to House and Senate budget leaders. “In prior ...
Breaking Medicine News(10 mins):